Aminocholestane and Aminoandrostane Inhibitors of the SH2 Domain-Containing Inositol 5'-Phosphatase (SHIP)
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Researchers developed more water-soluble aminosteroid inhibitors targeting SH2-containing inositol phosphatase (SHIP) enzymes. These novel compounds inhibit both SHIP1 and SHIP2, offering potential for studying these enzymes in diseases like Alzheimer's and cancer.
Area Of Science
- Biochemistry
- Medicinal Chemistry
- Pharmacology
Background
- SH2-containing inositol phosphatase (SHIP) is a therapeutic target for Alzheimer's Disease, Graft-vs-Host disease, obesity, and cancer.
- Aminosteroid SHIP inhibitors, such as 3α-aminocholestane (3AC), are under investigation.
- Improving the water solubility of SHIP inhibitors is crucial for their therapeutic development.
Purpose Of The Study
- To synthesize and evaluate novel aminosteroid analogs of 3AC with enhanced water solubility.
- To investigate the inhibitory activity of these analogs against SHIP1 and SHIP2.
- To elucidate the mechanism of inhibition and binding interactions within the SHIP active site.
Main Methods
- Chemical synthesis of aminosteroid analogs with modifications to the cholestane skeleton.
- Enzyme inhibition assays to determine the activity against SHIP1 and SHIP2.
- Enzyme kinetics studies to characterize the mode of inhibition.
- Molecular modeling to visualize inhibitor binding within the SHIP1 active site.
Main Results
- Analogs with deletion of the C17 alkyl group exhibited improved water solubility.
- These modified compounds demonstrated inhibition of both SHIP1 and SHIP2 (pan-SHIP1/2 inhibition).
- Enzyme kinetics indicated competitive inhibition, with binding near the substrate site.
- A binding model for SHIP1 was proposed based on structure-activity relationships.
Conclusions
- Novel, water-soluble aminosteroid pan-SHIP1/2 inhibitors have been developed.
- These compounds provide valuable tools for future research into SHIP enzyme functions and therapeutic applications.
- The findings contribute to the understanding of SHIP-targeted drug design for various diseases.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...